Shaomeng Wang
Molecular Biology · 2002–2019
A researcher in the Science corpus: 12 papers; trusts 6 researchers and is trusted by 24 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 73 citations into it; #1,655 of 17,773 by trust here, #1,476 by citations
- Computational Chemistry & Drug Discovery — 23 citations into it; #62 of 425 by trust here, #46 by citations
- Computational Theory and Mathematics — 12 citations into it; #1,637 of 12,182 by trust here, #188 by citations
Whom Shaomeng Wang trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Shaomeng Wang overall
- Pedro J. Ballester
- Shengyou Huang
- Pedro H. M. Torres
- Elizabeth Yuriev
- John B. O. Mitchell
- Xiaoqin Zou
- R. Quiroga
- Zhong-Ru Xie
- Kun-Yi Hsin
- Sérgio Filipe Sousa
Papers from Shaomeng Wang's perspective
Ordered by how strongly the researchers Shaomeng Wang trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming.
- Surfing the p53 network (Nature)
- A fast flexible docking method using an incremental construction algorithm.
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 (Science)
- Further development and validation of empirical scoring functions for structure-based binding affinity prediction
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition (Proceedings of the National Academy of Sciences of the United States of America)
- Chalcones: an update on cytotoxic and chemoprotective properties. (Current Medicinal Chemistry)
- Progress and challenges in protein structure prediction.
- TM-align: a protein structure alignment algorithm based on the TM-score
- The I-TASSER Suite: protein structure and function prediction
Their papers
- The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures. (2004) — 1,058 citations
- Changing the Apoptosis Pathway through Evolutionary Protein Design (2019) — 21 citations
- The PDBbind database: methodologies and updates. (2005) — 893 citations
- Comparative evaluation of 11 scoring functions for molecular docking. (2003) — 851 citations
- Further development and validation of empirical scoring functions for structure-based binding affinity prediction (2002) — 1,084 citations
- Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. (2013) — 626 citations
- Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy (2009) — 601 citations
- Structure-based design of potent non-peptide MDM2 inhibitors. (2005) — 616 citations
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition (2008) — 654 citations
- Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer (2014) — 897 citations
- M-score: a knowledge-based potential scoring function accounting for protein atom mobility. (2006) — 58 citations
- Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction. (2006) — 643 citations